Pharmacology of Protein Binding of Drugs - An Extensive Review
Biomedical & Pharmacology Journal · 26.06.2026 · 2 (19) · 1206
DOI: 10.13005/bpj/3419 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical & Pharmacology Journal, online erschienen am 25.06.2026. Verfasst von Mohammad Shah Amran und 5 weiteren Autor:innen. Die Arbeit nennt 146 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Protein binding is a fundamental determinant of drug pharmacokinetics and pharmacodynamics, influencing drug distribution, efficacy, toxicity, metabolism, and elimination. Most drugs interact with plasma proteins such as albumin, α1-acid glycoprotein (AAG), and lipoproteins, with the extent and nature of binding depending on physicochemical properties of the drug as well as physiological and pathological factors. Albumin predominantly binds acidic and neutral drugs, whereas AAG preferentially binds basic compounds. Lipoproteins serve as important carriers for highly lipophilic drugs, thereby affecting their distribution and clearance. The pharmacologically active fraction of a drug is the unbound portion, making protein binding a critical factor in determining therapeutic response and adverse effects. This review provides a comprehensive overview of the mechanisms and principles of drug-protein interactions, the major plasma proteins involved, and their influence on drug disposition. It further examines factors that alter protein binding, including disease states, age-related physiological changes, protein concentration variability, species differences, drug-drug interactions, food–drug interactions, and drug-metal interactions. The clinical implications of altered protein binding are discussed with reference to selected therapeutic agents, highlighting the importance of monitoring unbound drug concentrations in specific patient populations. By integrating classical concepts with recent advances in the understanding of plasma protein binding, this review underscores the pivotal role of drug–protein interactions in optimizing pharmacotherapy, improving therapeutic outcomes, and minimizing toxicity.
Zitieren
APA
Amran, M. S., Shristy, F. A., Mouree, T. Z., Bondhon, S. B. S., Kabir, S., & Aktar, F. (2026). Pharmacology of Protein Binding of Drugs - An Extensive Review. Biomedical & Pharmacology Journal, 2(19), 1206. https://doi.org/10.13005/bpj/3419
Vancouver
Amran MS, Shristy FA, Mouree TZ, Bondhon SBS, Kabir S, Aktar F. Pharmacology of Protein Binding of Drugs - An Extensive Review. Biomedical & Pharmacology Journal. 2026;2(19):1206. doi:10.13005/bpj/3419
BibTeX
@article{Amran2026,
author = {Amran, Mohammad Shah and Shristy, Fareha Anan and Mouree, Tashfiya Zaman and Bondhon, Saif Bin Salam and Kabir, Shaila and Aktar, Fahima},
title = {Pharmacology of Protein Binding of Drugs - An Extensive Review},
journal = {Biomedical & Pharmacology Journal},
year = {2026},
volume = {2},
number = {19},
pages = {1206},
doi = {10.13005/bpj/3419}
}
EUVIMED